HomeCompareEBRPF vs JNJ

EBRPF vs JNJ: Dividend Comparison 2026

EBRPF yields 3.69% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EBRPF wins by $293.00 in total portfolio value
10 years
EBRPF
EBRPF
● Live price
3.69%
Share price
$21.28
Annual div
$0.79
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.3K
Annual income
$0.37
Full EBRPF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — EBRPF vs JNJ

📍 EBRPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEBRPFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EBRPF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EBRPF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EBRPF
Annual income on $10K today (after 15% tax)
$314.04/yr
After 10yr DRIP, annual income (after tax)
$0.31/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $703.30/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EBRPF + JNJ for your $10,000?

EBRPF: 50%JNJ: 50%
100% JNJ50/50100% EBRPF
Portfolio after 10yr
$20.2K
Annual income
$414.08/yr
Blended yield
2.05%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

EBRPF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
4.1
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EBRPF buys
0
JNJ buys
0
No recent congressional trades found for EBRPF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEBRPFJNJ
Forward yield3.69%3.36%
Annual dividend / share$0.79$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR-50%5.8%
Portfolio after 10y$20.3K$20.0K
Annual income after 10y$0.37$827.78
Total dividends collected$373.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: EBRPF vs JNJ ($10,000, DRIP)

YearEBRPF PortfolioEBRPF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,885$184.73$10,676$355.77+$209.00EBRPF
2$11,741$93.96$11,407$389.39+$334.00EBRPF
3$12,610$47.36$12,198$426.53+$412.00EBRPF
4$13,516$23.77$13,056$467.62+$460.00EBRPF
5$14,474$11.91$13,987$513.12+$487.00EBRPF
6$15,493$5.96$14,998$563.56+$495.00EBRPF
7$16,581$2.98$16,098$619.52+$483.00EBRPF
8$17,743$1.49$17,295$681.69+$448.00EBRPF
9$18,986$0.75$18,599$750.82+$387.00EBRPF
10$20,315$0.37$20,022$827.78+$293.00EBRPF

EBRPF vs JNJ: Complete Analysis 2026

EBRPFStock

Ebro Foods, S.A. produces and sells food products in Spain, rest of Europe, the United States, and internationally. The company offers various rice varieties; ancient grains, such as quinoa, chia, and bulgur; organic food products; and vegetable protein products under various brands. It primarily serves food distributors, food multinationals, and restaurants. The company was formerly known as Ebro Puleva, S.A. and changed its name to Ebro Foods, S.A. in June 2010. Ebro Foods, S.A. was incorporated in 1998 and is headquartered in Madrid, Spain.

Full EBRPF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this EBRPF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EBRPF vs SCHDEBRPF vs JEPIEBRPF vs OEBRPF vs KOEBRPF vs MAINEBRPF vs ABBVEBRPF vs MRKEBRPF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.